Prof. Xiaoyi Ding 丁晓毅
Chief Physician, Professor
Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional radiology for malignant tumors of the liver, lung, pancreas, breast, bone, and gynecologic system. Specializes in irreversible electroporation (NanoKnife) ablation for pancreatic, hilar, and retroperitoneal malignancies. Performs vascular interventions, tumor ablation, stenting, biopsies, and pain management.
Dr. Ding is Chief Physician and Professor at Ruijin Hospital. Trained in France (2000–2001) under Prof. J.L. Dietenan and Prof. A.F. Gangi. Introduced CT-guided biopsies and drainage in 1991, spinal interventions in 1995, and vertebroplasty and tumor ablation in 2001. Began NanoKnife ablation for complex malignancies in 2015.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member, National Tumor Minimally Invasive Therapy Industry Technology Innovation Strategic Alliance Expert Committee
- Vice Chair, Liver Cancer Expert Committee, National Tumor Minimally Invasive Therapy Industry Technology Innovation Strategic Alliance
- Standing Committee Member and Head of Imaging Diagnosis Group, Sarcoma Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Ding Xiaoyi). Papers usually list the name as Xiaoyi Ding or Ding X.
Selected publications
85 papers on PubMed matched by name and affiliation; 22 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2026 (senior author): D-xylose suppresses hepatocellular carcinoma progression by regulating dihydrodiol dehydrogenase and remodeling the immune microenvironment. PubMed 41909699
- Int J Med Sci, 2025 (senior author): Single-Gene Mutations in Hepatocellular Carcinoma: Applications and Challenges in Precision Medicine. PubMed 40765562
- Eur J Med Res, 2025 (senior author): Advances in the application of extracellular vesicles in precise diagnosis of pancreatic cancer. PubMed 40514731
- J Thorac Imaging, 2024 (senior author): Computed Tomography-guided Percutaneous Lung Biopsy With Electromagnetic Navigation Compared With Conventional Approaches: An Open-label, Randomized Controlled Trial. PubMed 37982518
- J Interv Med, 2023 (senior author): The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy. PubMed 37846332
- Clin Transl Oncol, 2022 (senior author): Tumor-infiltrating OX40(+) lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. PubMed 35731350
- J Interv Med, 2022 (senior author): Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices. PubMed 36317150
- Am J Cancer Res, 2021 (senior author): OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model. PubMed 34249428
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion